Literature DB >> 20957478

Acute-phase reactants and a supplemental diagnostic aid for Kawasaki disease.

Ming-Yii Huang1, Monesha Gupta-Malhotra, Joh-Jong Huang, Fei-Kai Syu, Teh-Yang Huang.   

Abstract

The diagnosis of acute Kawasaki disease (KD) is based on characteristic clinical signs and not on a specific diagnostic test. The authors performed a comprehensive evaluation of acute-phase reactants in KD to determine which of the acute-phase reactants would most accurately distinguish KD from other febrile illnesses. Blood was collected from 218 cases of febrile children with KD (64 cases); bacterial pneumonia (74 cases); hand, foot, and mouth disease (31 cases); and upper respiratory tract infection (49 cases) in acute-stage illness before any therapy. The demographics, body temperature, and laboratory markers including white blood cell count, red blood cell count, and levels of hemoglobin, platelets, C-reactive protein, haptoglobin, apolipoprotein A-I, and apolipoprotein B were evaluated. Using post hoc analysis, the platelet count (10(3)/μl) and haptoglobin/apolipoprotein A-I ratio were significantly higher for the KD patients (404.64 ± 161.68, P = 0.004; 4.74 ± 2.73, P < 0.001) than for the other groups including patients with pneumonia (272.76 ± 115.07, 2.03 ± 1.88); hand, foot, and mouth disease (274 ± 105.9, 2.24 ± 1.19); and upper respiratory tract infection (282.06 ± 107.72, 1.4 ± 0.98). The best cutoff value of the haptoglobin/apolipoprotein A-I ratio obtained from receiver operating characteristics (ROC) curves for KD was 2 (area under the ROC curve, 0.88; 95% confidence interval, 0.801-0.955), with a sensitivity of 89.7% and a specificity of 85.6% for detecting KD. Our data indicate that the serum haptoglobin/apolipoprotein A-I ratio could be a useful supplemental laboratory marker for the acute phase of KD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957478      PMCID: PMC3933282          DOI: 10.1007/s00246-010-9801-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Basic principles of ROC analysis.

Authors:  C E Metz
Journal:  Semin Nucl Med       Date:  1978-10       Impact factor: 4.446

Review 2.  Accuracy of diagnostic tests read with and without clinical information: a systematic review.

Authors:  Clement T Loy; Les Irwig
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

3.  Late diagnosis of Kawasaki disease is associated with haptoglobin phenotype.

Authors:  W C Lee; K P Hwang; Y T King; H C Chen; S S Chiou; R C Yang; T Y Huang
Journal:  Eur J Clin Invest       Date:  2000-05       Impact factor: 4.686

4.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

5.  Kawasaki syndrome: a new infectious disease?

Authors:  M E Melish
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

6.  The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

Authors:  Y Ueno; N Takano; H Kanegane; T Yokoi; A Yachie; T Miyawaki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

8.  Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).

Authors:  C Y Lin; B Hwang
Journal:  Ann Allergy       Date:  1987-10

9.  Altered lipid profile after Kawasaki syndrome.

Authors:  J W Newburger; J C Burns; A S Beiser; J Loscalzo
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

10.  Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma.

Authors:  Ryan J Henderson; Kishor M Wasan; Carlos G Leon
Journal:  Lipids Health Dis       Date:  2009-07-23       Impact factor: 3.876

View more
  10 in total

1.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Point-of-care differentiation of Kawasaki disease from other febrile illnesses.

Authors:  Xuefeng B Ling; John T Kanegaye; Jun Ji; Sihua Peng; Yuichiro Sato; Adriana Tremoulet; Jane C Burns; Harvey J Cohen
Journal:  J Pediatr       Date:  2012-07-20       Impact factor: 4.406

3.  Proteomic Profiling of Cryoglobulinemia.

Authors:  Peng Liu; Jianqiang Wu; Dandan Sun; Haolong Li; Zhihong Qi; Xiaoyue Tang; Wei Su; Yongzhe Li; Xuzhen Qin
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

4.  Challenges in early diagnosis of Kawasaki disease in the pediatric emergency department: differentiation from adenoviral and invasive pneumococcal disease.

Authors:  Lorna Stemberger Maric; Neven Papic; Mario Sestan; Ivica Knezovic; Goran Tesovic
Journal:  Wien Klin Wochenschr       Date:  2018-02-23       Impact factor: 1.704

5.  Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.

Authors:  Fernanda Falcini; Serena Capannini; Donato Rigante
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-20       Impact factor: 3.054

Review 6.  Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.

Authors:  Donato Rigante; Laura Andreozzi; Michele Fastiggi; Benedetta Bracci; Marco Francesco Natale; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

7.  The Blood Gene Expression Signature for Kawasaki Disease in Children Identified with Advanced Feature Selection Methods.

Authors:  Bing Hu; Yun Li; Guilian Wang; Yanqing Zhang
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

8.  Distinguishing Kawasaki Disease from Febrile Infectious Disease Using Gene Pair Signatures.

Authors:  Jiayong Zhong; Qingsheng Huang; Yanfei Wang; Huan Gao; Hongling Jia; Jun Fan; Huiying Liang
Journal:  Biomed Res Int       Date:  2020-04-26       Impact factor: 3.411

9.  Cerebrospinal fluid changes and clinical features of aseptic meningitis in patients with Kawasaki disease.

Authors:  Fan Hu; Xiaoqing Shi; Yang Fan; Hanmin Liu; Kaiyu Zhou
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

10.  Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.

Authors:  Alex Kentsis; Andrew Shulman; Saima Ahmed; Eileen Brennan; Michael C Monuteaux; Young-Ho Lee; Susan Lipsett; Joao A Paulo; Fatma Dedeoglu; Robert Fuhlbrigge; Richard Bachur; Gary Bradwin; Moshe Arditi; Robert P Sundel; Jane W Newburger; Hanno Steen; Susan Kim
Journal:  EMBO Mol Med       Date:  2012-12-20       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.